Antisense technology to lower LDL cholesterol.
Neely
R Dermot G
RD
Clinical Biochemistry Department, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK. Dermot.Neely@nuth.nhs.uk
Bassendine
Margaret F
MF
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D053299:Apolipoprotein B-100 / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D009841:Oligonucleotides / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D053299:Apolipoprotein B-100; D008078:Cholesterol, LDL; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense; C524142:mipomersen